Skip to main content
Log in

Interactions of zearalenone and its reduced metabolites α-zearalenol and β-zearalenol with serum albumins: species differences, binding sites, and thermodynamics

  • Original Article
  • Published:
Mycotoxin Research Aims and scope Submit manuscript

Abstract

Zearalenone (ZEN) is a mycotoxin produced by Fusarium species. ZEN mainly appears in cereals and related foodstuffs, causing reproductive disorders in animals, due to its xenoestrogenic effects. The main reduced metabolites of ZEN are α-zearalenol (α-ZEL) and β-zearalenol (β-ZEL). Similarly to ZEN, ZELs can also activate estrogen receptors; moreover, α-ZEL is the most potent endocrine disruptor among these three compounds. Serum albumin is the most abundant plasma protein in the circulation; it affects the tissue distribution and elimination of several drugs and xenobiotics. Although ZEN binds to albumin with high affinity, albumin-binding of α-ZEL and β-ZEL has not been investigated. In this study, the complex formation of ZEN, α-ZEL, and β-ZEL with human (HSA), bovine (BSA), porcine (PSA), and rat serum albumins (RSA) was investigated by fluorescence spectroscopy, affinity chromatography, thermodynamic studies, and molecular modeling. Our main observations are as follows: (1) ZEN binds with higher affinity to albumins than α-ZEL and β-ZEL. (2) The low binding affinity of β-ZEL toward albumin may result from its different binding position or binding site. (3) The binding constants of the mycotoxin-albumin complexes significantly vary with the species. (4) From the thermodynamic point of view, the formation of ZEN-HSA and ZEN-RSA complexes are similar, while the formation of ZEN-BSA and ZEN-PSA complexes are markedly different. These results suggest that the toxicological relevance of ZEN-albumin and ZEL-albumin interactions may also be species-dependent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

Download references

Acknowledgements

This project was supported by the János Bolyai Research Scholarship of the Hungarian Academy of Sciences (M.P.). M.P. is thankful for support of the University of Pécs for grant in the frame of Pharmaceutical Talent Centre program. This work was supported by the GINOP-2.3.2-15-2016-00049 grant. We acknowledge a grant of computer time from CSCS Swiss National Supercomputing Centre, and NIIF Hungarian National Information Infrastructure Development Institute. We acknowledge that the results of this research have been achieved using the DECI resource Archer based in the UK at the National Supercomputing Service with support from the PRACE aisbl. M.B. and C.H. are thankful to the University of Pécs for the grant in the frame of “Supporting Individual Research and Innovation Activity of Young Researchers, 2018” program.

Funding

This project was supported by the Hungarian National Research, Development and Innovation Office (FK125166) (M.P.). The work of M.B. and C.H. is supported by the Hungarian National Research, Development and Innovation Office (K123836).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miklós Poór.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest. We have full control of all primary data and we agree to allow the journal to review our data if requested.

Electronic supplementary material

ESM 1

(DOCX 2834 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faisal, Z., Lemli, B., Szerencsés, D. et al. Interactions of zearalenone and its reduced metabolites α-zearalenol and β-zearalenol with serum albumins: species differences, binding sites, and thermodynamics. Mycotoxin Res 34, 269–278 (2018). https://doi.org/10.1007/s12550-018-0321-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12550-018-0321-6

Keywords

Profiles

  1. Miklós Poór